Centre of Excellence for Applied Development of Ayurveda Prakriti and Genomics, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India.
CSIR Ayurgenomics Unit-TRISUTRA, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India.
Cell Cycle. 2021 May;20(9):903-913. doi: 10.1080/15384101.2021.1909884. Epub 2021 Apr 18.
Differences in human phenotypes and susceptibility to complex diseases are an outcome of genetic and environmental interactions. This is evident in diseases that progress through a common set of intermediate patho-endophenotypes. Precision medicine aims to delineate molecular players for individualized and early interventions. Functional studies of lymphoblastoid cell line (LCL) model of phenotypically well-characterized healthy individuals can help deconvolute and validate these molecular mechanisms. In this study, LCLs are developed from eight healthy individuals belonging to three extreme constitution types, deep phenotyped on the basis of Ayurveda. LCLs were characterized by karyotyping and immunophenotyping. Growth characteristics and response to UV were studied in these LCLs. Significant differences in cell proliferation rates were observed between the contrasting groups such that one type () proliferates significantly slower than the other two (). In response to UV, one of the fast growing groups () shows higher cell death but recovers its numbers due to an inherent higher rates of proliferation. This study reveals that baseline differences in cell proliferation could be a key to understanding the survivability of cells under UV stress. Variability in baseline cellular phenotypes not only explains the cellular basis of different constitution types but can also help set priors during the design of an individualized therapy with DNA damaging agents. This is the first study of its kind that shows variability of intermediate patho-phenotypes among healthy individuals with potential implications in precision medicine.
人类表型和对复杂疾病易感性的差异是遗传和环境相互作用的结果。这在通过一组常见中间病理表型进展的疾病中显而易见。精准医学旨在确定用于个体化和早期干预的分子参与者。表型特征良好的健康个体的淋巴母细胞系 (LCL) 模型的功能研究有助于剖析和验证这些分子机制。在这项研究中,LCL 是从属于三种极端体质类型的八名健康个体中开发的,根据阿育吠陀进行了深度表型分析。通过核型分析和免疫表型分析对 LCL 进行了表征。研究了这些 LCL 的生长特性和对 UV 的反应。在对比组之间观察到细胞增殖率存在显着差异,使得一种类型 () 比另外两种 () 增殖明显缓慢。对 UV 的反应中,快速生长的组之一 () 显示出更高的细胞死亡,但由于固有更高的增殖率,其数量得以恢复。这项研究表明,细胞增殖的基线差异可能是理解细胞在 UV 应激下生存能力的关键。基线细胞表型的可变性不仅解释了不同体质类型的细胞基础,还可以在设计针对 DNA 损伤剂的个体化治疗时帮助设定先验概率。这是第一项表明健康个体中间病理表型存在可变性的此类研究,可能对精准医学具有重要意义。